On Friday, Vistagen Therapeutics Inc (NASDAQ: VTGN) opened higher 7.93% from the last session, before settling in for the closing price of $4.54. Price fluctuations for VTGN have ranged from $1.90 to $5.14 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 35.63%. Company’s average yearly earnings per share was noted -1.68% at the time writing. With a float of $31.98 million, this company’s outstanding shares have now reached $38.89 million.
Vistagen Therapeutics Inc (VTGN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vistagen Therapeutics Inc is 19.03%, while institutional ownership is 44.96%.
Vistagen Therapeutics Inc (VTGN) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.46 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.52) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.26% during the next five years compared to 35.63% growth over the previous five years of trading.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Trading Performance Indicators
Check out the current performance indicators for Vistagen Therapeutics Inc (VTGN). In the past quarter, the stock posted a quick ratio of 5.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 276.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Vistagen Therapeutics Inc (VTGN)
Looking closely at Vistagen Therapeutics Inc (NASDAQ: VTGN), its last 5-days average volume was 0.87 million, which is a jump from its year-to-date volume of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 68.23%.
During the past 100 days, Vistagen Therapeutics Inc’s (VTGN) raw stochastic average was set at 91.70%, which indicates a significant increase from 84.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.40 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.01, while its 200-day Moving Average is $2.96. However, in the short run, Vistagen Therapeutics Inc’s stock first resistance to watch stands at $5.05. Second resistance stands at $5.21. The third major resistance level sits at $5.44. If the price goes on to break the first support level at $4.66, it is likely to go to the next support level at $4.43. Should the price break the second support level, the third support level stands at $4.27.
Vistagen Therapeutics Inc (NASDAQ: VTGN) Key Stats
There are currently 39,495K shares outstanding in the company with a market cap of 193.53 million. Presently, the company’s annual sales total 490 K according to its annual income of -51,420 K. Last quarter, the company’s sales amounted to 260 K and its income totaled -19,420 K.
